BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3346407)

  • 21. Use of a diuretic combination of triamterene and hydrochlorothiazide in elderly patients.
    Bender AD; Carter CL; Hansen KB
    J Am Geriatr Soc; 1967 Feb; 15(2):166-73. PubMed ID: 5334664
    [No Abstract]   [Full Text] [Related]  

  • 22. Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases.
    Chen M; Crowson AN; Woofter M; Luca MB; Magro CM
    J Rheumatol; 2004 Apr; 31(4):818-20. PubMed ID: 15088316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case report: verapamil-induced subacute cutaneous lupus erythematosus.
    Kurtis B; Larson MJ; Hoang MP; Cohen JB
    J Drugs Dermatol; 2005; 4(4):506-8. PubMed ID: 16004027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrogenic diabetes insipidus associated with Dyazide (triamterene-hydrochlorothiazide).
    Macleod MD; Bell GM; Irvine WJ
    Br Med J (Clin Res Ed); 1981 Oct; 283(6300):1155-6. PubMed ID: 6794799
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized.
    Callen JP
    J Am Acad Dermatol; 2001 Aug; 45(2):315-6. PubMed ID: 11464200
    [No Abstract]   [Full Text] [Related]  

  • 26. Subacute-cutaneous lupus erythematosus induced by Simvastatin.
    Rüger RD; Simon JC; Treudler R
    J Dtsch Dermatol Ges; 2011 Jan; 9(1):54-5. PubMed ID: 21040470
    [No Abstract]   [Full Text] [Related]  

  • 27. [Subacute cutaneous lupus erythematosus induced by golimumab].
    Blasco-Morente G; Notario-Ferreira I; Rueda-Villafranca B; Tercedor-Sánchez J
    Med Clin (Barc); 2015 Sep; 145(5):226-7. PubMed ID: 25547737
    [No Abstract]   [Full Text] [Related]  

  • 28. Lupus erythematosus-like eruption due to D-penicillamine in progressive systemic sclerosis.
    Tsankov NK; Lazarova AZ; Vasileva SG; Obreshkova EV
    Int J Dermatol; 1990 Oct; 29(8):571-4. PubMed ID: 2147020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in serum potassium levels occurring in patients treated with triamterene and a triamterene-hydrochlorothiazide combination.
    Hansen KB; Bender AD
    Clin Pharmacol Ther; 1967; 8(3):392-9. PubMed ID: 6026787
    [No Abstract]   [Full Text] [Related]  

  • 30. Golimumab-exacerbated subacute cutaneous lupus erythematosus.
    Wilkerson E; Hazey MA; Bahrami S; Callen JP
    Arch Dermatol; 2012 Oct; 148(10):1186-90. PubMed ID: 23069957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced anti-Ro positive subacute cutaneous lupus in a man treated with olmesartan.
    Gray T; Segars K; Farsi M; Ross R; Miller R
    Dermatol Online J; 2019 Dec; 25(12):. PubMed ID: 32045161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acebutolol-induced subacute cutaneous lupus erythematosus.
    Fenniche S; Dhaoui A; Ammar FB; Benmously R; Marrak H; Mokhtar I
    Skin Pharmacol Physiol; 2005; 18(5):230-3. PubMed ID: 16015021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triamterene nephrolithiasis.
    Dooley DP; Callsen ME; Geiling JA
    Mil Med; 1989 Mar; 154(3):126-7. PubMed ID: 2496337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
    Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK; Bannon JA
    Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract]   [Full Text] [Related]  

  • 36. Amantadine-dyazide interaction.
    Wilson TW; Rajput AH
    Can Med Assoc J; 1983 Nov; 129(9):974-5. PubMed ID: 6671185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide).
    Hollenberg NK; Mickiewicz CW
    Am J Cardiol; 1989 Jan; 63(4):37B-41B. PubMed ID: 2911994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
    Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
    [No Abstract]   [Full Text] [Related]  

  • 40. Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
    Wiznia LE; Subtil A; Choi JN
    JAMA Dermatol; 2013 Sep; 149(9):1071-5. PubMed ID: 23842655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.